<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35357097</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">2191-0251</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>35</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>25</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of pediatric endocrinology &amp; metabolism : JPEM</Title>
          <ISOAbbreviation>J Pediatr Endocrinol Metab</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pediatric adrenal insufficiency: thirty years experience at a Portuguese hospital.</ArticleTitle>
        <Pagination>
          <StartPage>631</StartPage>
          <EndPage>638</EndPage>
          <MedlinePgn>631-638</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/jpem-2021-0725</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Adrenal insufficiency (AI) is a life-threatening condition caused by an impaired secretion of the adrenal glucocorticoid and mineralocorticoid hormones. It comprises a heterogeneous group of primary, secondary and acquired disorders. Presentation differs according to the child's age, but it usually presents with nonspecific and insidious symptoms and signs. The main purpose of this study was to describe and compare patients with primary or secondary AI.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective analysis of all patients with adrenal insufficiency followed at the Pediatric Endocrinology Unit in a tertiary care Portuguese hospital over the last 30 years. Data on family history, age at the first manifestation and at etiological diagnosis, and clinical presentation (symptoms, signs and laboratory evaluation) was gathered for all patients.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-eight patients with AI were included; 67.9% were male, with a median (25th-75th percentile, P25-P75) age of 1 (0.5-36) month at the first presentation. The principal diagnostic categories were panhypopituitarism (42.9%) and congenital adrenal hyperplasia (25%). The most frequent manifestations (75%) were vomiting and weight loss. They were followed for a median (P25-P75) period of 3.5 (0.6-15.5) years. In respect to neurodevelopmental delay and learning difficulties, they were more common in the secondary AI group.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite medical advances, the diagnosis and management of AI remains a challenge, particularly in the pediatric population, and clinicians must have a high index of suspicion. An early identification of AI can prevent a potential lethal outcome, which may result from severe cardiovascular and hemodynamic instability.</AbstractText>
          <CopyrightInformation>© 2022 Walter de Gruyter GmbH, Berlin/Boston.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mosca</LastName>
            <ForeName>Sara M F S</ForeName>
            <Initials>SMFS</Initials>
            <Identifier Source="ORCID">0000-0002-5474-7236</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Pediatric Endocrinology Unit, Centro Materno-Infantil do Norte, Centro Hospitalar Universitário do Porto (CMIN-CHUPorto), Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santos</LastName>
            <ForeName>Tiago S</ForeName>
            <Initials>TS</Initials>
            <Identifier Source="ORCID">0000-0001-8729-2787</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Diabetes and Metabolism, CHUPorto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mendes</LastName>
            <ForeName>Ana C B</ForeName>
            <Initials>ACB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Pediatric Endocrinology Unit, Centro Materno-Infantil do Norte, Centro Hospitalar Universitário do Porto (CMIN-CHUPorto), Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ribeiro</LastName>
            <ForeName>Luís F M</ForeName>
            <Initials>LFM</Initials>
            <Identifier Source="ORCID">0000-0002-2768-9819</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Pediatric Endocrinology Unit, Centro Materno-Infantil do Norte, Centro Hospitalar Universitário do Porto (CMIN-CHUPorto), Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Freitas</LastName>
            <ForeName>Joana M C</ForeName>
            <Initials>JMC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Pediatric Endocrinology Unit, Centro Materno-Infantil do Norte, Centro Hospitalar Universitário do Porto (CMIN-CHUPorto), Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oliveira</LastName>
            <ForeName>Maria J R</ForeName>
            <Initials>MJR</Initials>
            <Identifier Source="ORCID">0000-0003-0661-8947</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Pediatric Endocrinology Unit, Centro Materno-Infantil do Norte, Centro Hospitalar Universitário do Porto (CMIN-CHUPorto), Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rocha</LastName>
            <ForeName>Carla A</ForeName>
            <Initials>CA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Pediatric Endocrinology Unit, Centro Materno-Infantil do Norte, Centro Hospitalar Universitário do Porto (CMIN-CHUPorto), Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Borges</LastName>
            <ForeName>Teresa M S</ForeName>
            <Initials>TMS</Initials>
            <Identifier Source="ORCID">0000-0002-8501-6639</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Pediatric Endocrinology Unit, Centro Materno-Infantil do Norte, Centro Hospitalar Universitário do Porto (CMIN-CHUPorto), Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>J Pediatr Endocrinol Metab</MedlineTA>
        <NlmUniqueID>9508900</NlmUniqueID>
        <ISSNLinking>0334-018X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000309" MajorTopicYN="Y">Adrenal Insufficiency</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007018" MajorTopicYN="Y">Hypopituitarism</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011174" MajorTopicYN="N" Type="Geographic">Portugal</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adrenal insufficiency</Keyword>
        <Keyword MajorTopicYN="N">hypoglycemia</Keyword>
        <Keyword MajorTopicYN="N">hyponatremia</Keyword>
        <Keyword MajorTopicYN="N">hypopituitarism</Keyword>
        <Keyword MajorTopicYN="N">pediatrics</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>31</Day>
          <Hour>8</Hour>
          <Minute>39</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35357097</ArticleId>
        <ArticleId IdType="doi">10.1515/jpem-2021-0725</ArticleId>
        <ArticleId IdType="pii">jpem-2021-0725</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Charmandari, E, Nicolaides, NC, Chrousos, GP. Adrenal insufficiency. Lancet 2014;383:2152–67, https://doi.org/10.1016/s0140-6736(13)61684-0.</Citation>
        </Reference>
        <Reference>
          <Citation>Chabre, O, Goichot, B, Zenaty, D, Bertherat, J. Group 1. Epidemiology of primary and secondary adrenal insufficiency: prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality. Ann Endocrinol 2017;78:490–4, https://doi.org/10.1016/j.ando.2017.10.010.</Citation>
        </Reference>
        <Reference>
          <Citation>Rushworth, RL, Torpy, DJ, Stratakis, CAFH. Adrenal crises in children: perspectives and research directions. Horm Res 2018;89:341–51, https://doi.org/10.1159/000481660.</Citation>
        </Reference>
        <Reference>
          <Citation>Hsieh, S, White, PC. Presentation of primary adrenal insufficiency in childhood. J Clin Endocrinol Metab 2011;96:925–8, https://doi.org/10.1210/jc.2011-0015.</Citation>
        </Reference>
        <Reference>
          <Citation>Ventura, M, Serra-Caetano, J, Cardoso, R, Dinis, I, Melo, M, Carrilho, F, et al.. The spectrum of pediatric adrenal insufficiency: insights from 34 years of experience. J Pediatr Endocrinol Metab 2019;32:721–6, https://doi.org/10.1515/jpem-2019-0030.</Citation>
        </Reference>
        <Reference>
          <Citation>Auron, M, Raissouni, N. Adrenal Insufficiency. NeoReviews 2015;36:92–103, https://doi.org/10.1542/pir.36-3-92.</Citation>
        </Reference>
        <Reference>
          <Citation>Grossman, AB. The diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metab 2010;95:4855–63, https://doi.org/10.1210/jc.2010-0982.</Citation>
        </Reference>
        <Reference>
          <Citation>Patti, G, Guzzeti, C, Di Iorgi, N, Maria Allegri, AE, Napoli, F, Loche, S, et al.. Central adrenal insufficiency in children and adolescents. Best Pract Res Clin Endocrinol Metabol 2018;32:425–44, https://doi.org/10.1016/j.beem.2018.03.012.</Citation>
        </Reference>
        <Reference>
          <Citation>Bancos, I, Hahner, S, Tomlinson, J, Arlt, W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol 2015;3:216–26, https://doi.org/10.1016/s2213-8587(14)70142-1.</Citation>
        </Reference>
        <Reference>
          <Citation>Perry, R, Kecha, O, Paquette, J, Huot, C, Van Vliet, G, Deal, C. Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal. J Clin Endocrinol Metab 2005;90:3243–50, https://doi.org/10.1210/jc.2004-0016.</Citation>
        </Reference>
        <Reference>
          <Citation>Proust-Lemoine, E, Reynaud, R, Delemer, B, Tabarin, A, Samara-Boustani, D. Group 3: strategies for identifying the cause of adrenal insufficiency: diagnostic algorithms. Ann Endocrinol 2017;78:512–24, https://doi.org/10.1016/j.ando.2017.10.006.</Citation>
        </Reference>
        <Reference>
          <Citation>Wijaya, M, Huamei, M, Jun, Z, Du, M, Li, Y, Chen, Q, et al.. Etiology of primary adrenal insufficiency in children: a 29-year single-center experience. J Pediatr Endocrinol Metab 2019;32:615–22, https://doi.org/10.1515/jpem-2018-0445.</Citation>
        </Reference>
        <Reference>
          <Citation>Cortet, C, Barat, P, Zenaty, D, Guignat, L, Chanson, P. Group 5: acute adrenal insufficiency in adults and pediatric patients. Ann Endocrinol 2017;78:535–43, https://doi.org/10.1016/j.ando.2017.10.008.</Citation>
        </Reference>
        <Reference>
          <Citation>Frisch, H, Waldhauser, F, Lebl, J, Solyom, J, Hargitai, G, Kovacs, J, et al.. Congenital adrenal hyperplasia: lessons from a multinational study. Horm Res 2002;57:95–101, https://doi.org/10.1159/000058109.</Citation>
        </Reference>
        <Reference>
          <Citation>Engelen, M, Kemp, S, De Visser, M, Van Geel, BM, Wanders, RJA, Aubourg, P, et al.. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 2012;7:1–14, https://doi.org/10.1186/1750-1172-7-51.</Citation>
        </Reference>
        <Reference>
          <Citation>Furlan, FLS, Lemes, MA, Suguimatsu, LCF, Pires, CTF, Santos, MLSF. X-linked adrenoleukodystrophy in Brazil: a case series. Rev Paul Pediatr 2019;37:465–71, https://doi.org/10.1590/1984-0462/;2019;37;4;00015.</Citation>
        </Reference>
        <Reference>
          <Citation>Gupta, S, Joshi, K, Zaidi, G, Sarangi, AN, Mandal, K, Bhavani, N, et al.. Novel mutations and spectrum of the disease of NR0B1 (DAX1)-related adrenal insufficiency in Indian children. J Pediatr Endocrinol Metab 2019;32:863–9, https://doi.org/10.1515/jpem-2018-0440.</Citation>
        </Reference>
        <Reference>
          <Citation>Burtman, E, Regelmann, MO. Endocrine dysfunction in X-linked adrenoleukodystrophy. Endocrinol Metab Clin N Am 2016;45:295–309, https://doi.org/10.1016/j.ecl.2016.01.003.</Citation>
        </Reference>
        <Reference>
          <Citation>Duro, IP, Mosca, S, Araújo, G, Lorenzo, J, Freitas, J, Oliveira, MJ, et al.. Neonatal adrenal insufficiency – beyond the common causes. J. Pediatr. Neonatal. Individ. Med. 2022;11:7–11.</Citation>
        </Reference>
        <Reference>
          <Citation>Bergthorsdottir, R, Leonsson-Zachrisson, M, Odén, A, Johannsson, G. Premature mortality in patients with Addison’s disease: a population-based study. J Clin Endocrinol Metab 2006;91:4849–53, https://doi.org/10.1210/jc.2006-0076.</Citation>
        </Reference>
        <Reference>
          <Citation>Ekman, B, Fitts, D, Marelli, C, Murray, RD, Quinkler, M, Zelissen, PMJ. European adrenal insufficiency registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy. BMC Endocr Disord 2014;14:40, https://doi.org/10.1186/1472-6823-14-40.</Citation>
        </Reference>
        <Reference>
          <Citation>Shulman, DI, Palmert, MR, Kemp, SF. Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics 2007;119:e484–94, https://doi.org/10.1542/peds.2006-1612.</Citation>
        </Reference>
        <Reference>
          <Citation>Bornstein, SR, Allolio, B, Arlt, W, Barthel, A, Don-Wauchope, A, Hammer, GD, et al.. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016;101:364–89, https://doi.org/10.1210/jc.2015-1710.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
